Vivek Ramaswamy, 10% Owner at Roivant Sciences Ltd. (ROIV), sold 3,709,206 shares at $20.51 ($75.9M) on 2025-11-17, disclosed to the SEC on 2025-11-17.
Open-market sale of $75.9M ROIV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.81 | 287,283 | $6.0M | 7.9% |
| 2 | $20.81 | 287,283 | $6.0M | 7.9% |
| 3 | $20.33 | 1,027,670 | $20.9M | 27.5% |
| 4 | $20.33 | 1,027,670 | $20.9M | 27.5% |
| 5 | $20.51 | 539,650 | $11.1M | 14.6% |
| 6 | $20.51 | 539,650 |
| $11.1M |
| 14.6% |
| Total | $20.46 avg | 3,709,206 | $75.9M | 100% |
| Filing → |
| ROIV | SELL | 2025-06-23 | $26.2M | — | Filing → |
| ROIV | SELL | 2025-06-06 | $14.7M | — | Filing → |
| ROIV | SELL | 2025-05-08 | $13.3M | — | Filing → |